Autoimmune retinopathy (AIR) is a rare, potentially blinding retinal disease that remains a challenging condition to manage when resistant to conventional immune-modulatory approaches. We report clinical and electrophysiological improvement in a 49-year-old patient who underwent an autologous hematopoietic stem cell transplant (aHSCT) for thymoma-associated AIR after experiencing progressive disease despite receiving periocular and systemic steroids, mycophenolate mofetil, baricitinib, tacrolimus, bortezomib, rituximab, plasmapheresis, and intravenous immunoglobulin. The aHSCT had two stages: (i) peripheral blood stem cell harvest following mobilization with cyclophosphamide and granulocyte colony-stimulating factor, and (ii) conditioning regimen with plasmapheresis, rituximab, cyclophosphamide, and anti-thymocyte globulin high-dose therapy, followed by autologous hematopoietic cell infusion of 5.
View Article and Find Full Text PDFTwo-dimensional SnSe (X = 1, 2) has emerged as a promising candidate for a NO chemiresistive sensor due to a remarkable affinity to NO gas adsorption. Although their gas sensing mechanism primarily relies on direct charge transfer, the underlying mechanisms of SnSe and SnSe remain unclear, despite various reported successes in phase engineering of SnSe. Here, we investigate phase engineering of SnSe in a hydrothermal route via 1-dodecanethiol (1-DDT), which served as a phase stabilizer, and comprehensively demonstrate phase-dependent NO detection properties.
View Article and Find Full Text PDFPurpose: To investigate the aqueous proteomics and metabolomics in low-energy and high-energy femtosecond laser-assisted cataract surgery (FLACS).
Methods: In this prospective observational study, 72 patients were randomized to 3 groups: low-energy FLACS, high-energy FLACS, and conventional phacoemulsification (controls). Aqueous was collected after femtosecond laser treatment or at the beginning of surgery (controls).
Background: To investigate the level of ganciclovir in the aqueous humour (AH) following topical application of 2.0% ganciclovir eye drop in eyes with cytomegalovirus (CMV) anterior segment infection.
Methods: This is a prospective, non-randomised, interventional clinical study.